吴磊+徐怀伏
摘 要 目的:在取消医保定点零售药店资格审查的趋势下,为我国连锁药店未来规模化发展提供参考意见。方法:描述分析法提出我国连锁药店存在低集中度和低连锁化等问题以及新政策带来的影响;利用波特五力模型,分析我国零售药店面临新的竞争环境,包括DTC、DTP的兴起以及上下游环节面临的挑战。结果及结论:新形势下,我国连锁药店企业应当通过并购、提供医疗服务、获取独家代理、加强供应链管理等途径提高核心竞争力,来应对外部竞争环境。
关键词 连锁药店 医保定点审批 医疗服务
中图分类号:F763; F721.7 文献标识码:C 文章编号:1006-1533(2016)03-0061-04
How to develop chain drugstores under the background of canceling the medical insurance fixed-point approval
WU Lei, XU Huaifu
(International Pharmaceutical Business School, China Pharmaceutical University, Nanjing 211198, China)
ABSTRACT Objective: To provide a reference for the scale development of chain drugstores in the future in China under the trend of canceling the medical insurance fixed-point approval. Methods: The existing problems such as low concentration and low chaining in Chinese chain drugstores and the effects of new policy on them were proposed by description method and the new competitive environment to be facing by retail pharmacies in China was analyzed by porters five model including the rise of DTC and DTPs as well as the challenge to be facing by the upstream and downstream sectors. Results & Conclusion: The Chinese enterprises working on the management of chain drugstore should improve their core competitiveness by mergers and acquisitions, providing medical services, getting an exclusive agent and strengthening the management of supply chain so as to deal with the external competitive environment.
KEY WORDS chain drugstores; medical insurance fixed-point approval; medical services
2015年10月,国务院印发《关于第一批取消62项中央指定地方实施行政审批事项的决定》,其中,取消医保定点零售药店资格审查项目是被药店行业视为重大利好的政策。零售药店定点审批原本是根据《国务院办公厅关于保留部分非行政许可审批项目的通知》设立的,实施以来,各地审批标准的差异阻碍了连锁药店的跨地区经营,不利于我国连锁药店的集中度。这项国务院特批的行政审批取消后,未来很有可能的趋势就是药店不需要审批就能获得医保定点资质,所有药店一视同仁,而变成药店与医保中心直接签协议。度食品药品监管统计年报》,截至2014年年底,我国实体药店总数达到434 920家,增长率为0.5%;其中零售连锁企业4 266家,与上年相比上升19.5%。图1显示,自2004年起我国连锁药店企业数量总体呈现上升趋势,2013年前连锁药店企业增长较为平缓,而2014年较上年增加了817家,增幅达到24%。……